Oncogenic signaling in CRC involves multiple pathways, notably EGFR/MAPK, WNT, Pi3K/Akt, JAK/STAT, Notch, SHH, and TGF-beta3,61. This evidence concerns the gene AKT1 and colorectal carcinoma.